Shares in Stratagene rose 22.4 percent over the five-day trading period ended Tuesday, far outgaining any of the other stocks that comprise the BCW Index. The gain is likely the result of investors believing that a recent sell off was unwarranted. Two weeks ago, the firm's shares dropped nearly 19 percent on news that a jury found the firm had willfully infringed patents held by Third Wave Technologies and ordered Stratagene to pay damages of $5.3 million (see BioCommerce Week 9/8/2005).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.